James W. McCollum
Director · LENZ Therapeutics, Inc.
- 2025
- Jun 16, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies James W. McCollum files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shawn Olsson - $261K in LENZ purchases and sales in the last 12 months
- Evert B. Schimmelpennink - $251K in LENZ purchases and sales in the last 12 months
- Daniel R. Chevallard - $114K in LENZ purchases and sales in the last 12 months
- Jeffrey P. George - $50K in LENZ purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James W. McCollum?
James W. McCollum is a corporate insider, tracked as Director of LENZ Therapeutics, Inc. (LENZ). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did James W. McCollum last file a Form 4?
The most recent primary Form 4 on record is dated 16 June 2026, one of 3 filings going back to 2025.
Has James W. McCollum been buying or selling stock?
Recorded transactions: 1 open-market purchase ($239K) and 0 open-market sales across all tracked filings.
